A shot every four weeks kept kidney function stable in IgA nephropathy for two years
In the final analysis of a phase 3 trial published Oct. 22, 2026, in the New England Journal of Medicine, sibeprenlimab kept kidney function stable over 24 months in IgA nephropathy, while…